Skip to content

October – November 2012 Orphan Drug Designations In Europe

December 20, 2012

       A positive opinion on orphan designation is given by the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) based in London, with the final decision made by the European Commission (EC). The COMP was created as part of the EU Regulation on Orphan Medicinal Products to review EU applications from persons or companies for the purpose of seeking orphan medicinal product designations.

       A list of October – November 2012 Orphan Drug Designations in the EC can be found on the EURORDIS website.  

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: